Table 2.
Comparison between adult and elderly patients: characteristics, indications, diagnostic and therapeutic yield, and adverse events.
| AGE < 65 Years (209/460, 45.4%) |
AGE ≥ 65 Years (251/460, 54.6%) |
p Value | |
|---|---|---|---|
| Sex | |||
| Male | 114 | 142 | 0.663 |
| Female | 95 | 109 | |
| Route | |||
| Anterograde | 147 | 202 | 0.011 |
| Retrograde | 62 | 49 | |
| CE | 150 | 212 | 0.001 |
| Indications | |||
| Radiology | 42 | 33 | 0.045 |
| CE | 127 | 185 | 0.003 |
| Inflammation | 27 | 17 | 0.026 |
| Polyp/Tumour | 52 | 37 | 0.006 |
| Angioectasia | 32 | 96 | <0.001 |
| Blood in lumen (without a clear lesion) | 16 | 35 | 0.032 |
| Symptoms | 8 | 3 | 0.122 |
| Crohn’s disease | 13 | 5 | <0.001 |
| OGIB | 15 | 21 | 0.636 |
| Iron-deficiency anaemia | 4 | 4 | 1.000 |
| Findings | 124 (59.3%) | 187 (74.5%) | 0.001 |
| Vascular lesions | 26 | 119 | <0.001 |
| Inflammation | 29 | 25 | 0.194 |
| Polyp/Tumour | 49 | 32 | 0.003 |
| Crohn’s disease | 17 | 6 | 0.005 |
| Other | 3 | 5 | 0.733 |
| Biopsy | 82 | 57 | <0.001 |
| Tattoo | 75 | 67 | 0.034 |
| Therapeutic | 31 | 115 | <0.001 |
| APC/clip | 18 | 107 | <0.001 |
| EMR | 13 | 7 | 0.072 |
| Complications | 3 | 2 | 0.664 |